About the platform
The mission of the Antibiotics platform is to bundle the existing expertise of antibiotic research in Switzerland with a focus on the discovery and development of novel antibiotics to treat multidrug resistant bacteria, as well as the development of rapid diagnostics. Networking activities facilitated through the Antibiotics platform shall foster research co-operations between industry and academia. Together, we innovate antibiotic development and provide opportunities for informal exchange. The platform organizes 1-2 networking events per year, typically accompanied with company or university visits.
Members / People
Industry
- Basilea Pharmaceutica Ltd. , Dr. Jürg Dreier
- BioVersys , Dr. Michel Pieren
- Idorsia Pharmaceuticals Ltd , Dr. Daniel Ritz
- Juvabis , Dr. Sven Hobbie
- LASCCO , Dr. Samareh Lajaunias
- leadXpro , Prof. Michael Hennig
- LimmaTech Biologics AG , Dr. Michael Kowarik
- Polyphor , Dr. Daniel Obrecht
- Resistell , Dr. Danuta Cichocka
- rqmicro , Dr. Hans-Anton Keserue
- F. Hoffmann-La Roche Ltd , Dr. Christoph Bieniossek
Academia
- ETH Zurich, Institute of Microbiology, Prof. Dr. Jörn Piel
- ETH Zurich, Institute of Pharmaceutical Sciences, Prof. Dr. Karl-Heinz Altmann
- ETH Zurich, Department of Health Sciences and Technology, Prof. Dr. Martin Loessner
- FHNW School of Life Sciences, Institute for Chemistry and Bioanalytics, Prof. Dr. Eric Kübler
- HES-SO Valais-Wallis, Institute of Life Technologies, Prof. Dr. Origène Nyanguile and Prof. Dr. Marc Mathieu
- University of Basel, Biozentrum, Prof. Dr. Christoh Dehio , Prof. Dr. Urs Jenal , Prof. Dr. Dirk Bumann , Prof. Dr. Sebastian Hiller , Prof. Dr. Médéric Diard
- University of Berne, Department of Chemistry and Biochemistry, Prof. Dr. Jean-Louis Reymond , PD Dr. Tamis Darbre
- University of Berne, Institute for Veterinary Bacteriology, Prof. Dr. Vincent Perreten
Organizations
- CARB-X accelerator Basel , Dr. Malcolm Page
- SNSF NRP72 program , Prof. Dr. Joachim Frey, Stéphane Praz
- NCCR Antiresist , Prof. Dr. Christoph Dehio
- Swiss Biotech Association (SBA) , Michael Altorfer
CTI-Projects of platform members
- Clinical impact of Resistell's AST on treatment decisions in bacteremia and sepsis and method validation for new indications. Resistell in collaboration with Prof. Gilbert Greub
- Swissbodies for antibiotics drug discovery. leadXpro in collaboration with Prof. Markus Seeger
- Development of early lead-like molecules targeting a bacterial transcriptional regulator to treat infections caused by the Gram-negative pathogen Acinetobacter baumannii. BioVersys in collaboration with Dr. Richard Kammerer, PSI
Join the platform
If you are interested in translational antibiotics and rapid diagnostics and wish to join the antibiotics platform: Please contact platform leader Prof. Dr. Markus Seeger
History
In 2015, biotechnet and the NTN SwissBiotech founded a novel platform dedicated to antibiotics development and rapid diagnostics. The discovery of antibiotics during the course of the 20th century was a milestone in the history of medicine. Today, a remarkable number of antibiotics still stem from the golden era of antibiotics development, which lasted roughly from 1945-1970. Unfortunately, antibiotics became victims of their own success; due to many treatment options and low prices, companies ceased to develop novel antibiotics, because other medical fields offered more attractive markets. In parallel, the existing antibiotics were misused as food additives in the animal industry and were prescribed to humans without being necessary. As a consequence, antimicrobial resmistance could spread worldwide, resulting in multiresistant pathogens which can no longer be treated with the current arsenal of antibiotics. Past Events
- 23. Sep 2021, 15.00 - 17.30 Extended Stakeholder Meeting - NRP72.
- 24. June 2021, 9.00 - 16.00 Promoting Innovative Antibiotic R & D in Switzerland Online event.
- 12.-13. March 2020 4th AMR Conference 2020: Novel Antimicrobials & AMR Diagnostics Congress Center Basel | Switzerland
- 10. September 2019 Platform meeting at BioVersys, Basel.
- 12. September 2018 (afternoon) Antibiotics brought by NTN SwissBiotech Innovation Forum at BASEL LIFE 2018
- 26. April 2018 Aiming for novel antibiotic approaches: Challenges, new technologies and potential collaborations. Innovation Event organized by BaselArea.Swiss
- 14. November 2017 Platform meeting at Vetsuisse Faculty, Bern.
- 16. October 2017 NTN Swiss Biotech Antibiotics Workshop, Bern. Organized by the Swiss Biotech Association.
- 20. June 2016 Platform meeting at Polyphor, Allschwil.
- 18. November 2015 Olten Meeting 2015. Antibiotics and Bioprinting.
- 08. September 2015 Founding meeting of the Antibiotics Platform in Bern.
